Average Co-Inventor Count = 4.19
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Immunogen, Inc. (43 from 255 patents)
2. Sanofi (6 from 1,454 patents)
3. Debiopharm International, S.a. (3 from 20 patents)
4. Sanof Aventis (1 from 1 patent)
53 patents:
1. 11932701 - Method for increasing the efficacy of cancer therapy by administering an anti-FOLR1 immunoconjugate
2. 11897961 - Anti-CD123 antibodies and conjugates and derivatives thereof
3. 11732038 - Conjugates comprising cell-binding agents and cytotoxic agents
4. 11466095 - CD37-binding molecules and immunoconjugates thereof
5. 11332535 - Anti-CD123 antibodies and conjugates and derivatives thereof
6. 11198736 - Method for identifying an ovarian cancer in a subject likely to respond to anti-folate receptor 1 (FOLR1) antibody
7. 11104740 - Antibodies and assays for detection of CD37
8. 10988531 - Conjugates comprising cell-binding agents and cytotoxic agents
9. 10919969 - Anti-CD123 antibodies and conjugates and derivatives thereof
10. 10875925 - Anti-CD123 antibodies and conjugates and derivatives thereof
11. 10752683 - Folate receptor 1 antibodies and immunoconjugates and uses thereof
12. 10613093 - Diagnostic assays and kits for detection of folate receptor 1
13. 10544230 - Methods of using antibodies to detect folate receptor 1 (FOLR1)
14. 10442865 - Methods of use of anti-CD123 antibodies and antigen-binding fragments thereof
15. 10301385 - Folate receptor 1 antibodies and immunoconjugates and uses thereof